On Friday, Ovid Therapeutics Inc (NASDAQ: OVID) was 9.70% up from the session before settling in for the closing price of $1.34. A 52-week range for OVID has been $0.24 – $2.01.
Healthcare Sector giant saw their annual sales surged by 24.72% over the last five years. When this article was written, the company’s average yearly earnings per share was at -28.35%. With a float of $58.39 million, this company’s outstanding shares have now reached $71.15 million.
Ovid Therapeutics Inc (OVID) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ovid Therapeutics Inc stocks. The insider ownership of Ovid Therapeutics Inc is 18.00%, while institutional ownership is 71.73%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.13 earnings per share (EPS) during the time that was better than consensus figure (set at -0.17) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.20% during the next five years compared to 24.72% growth over the previous five years of trading.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
You can see what Ovid Therapeutics Inc (OVID) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Analysing the last 5-days average volume posted by the [Ovid Therapeutics Inc, OVID], we can find that recorded value of 1.48 million was lower than the volume posted last year of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 22.69%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 64.82%, which indicates a significant increase from 39.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1310 in the past 14 days, which was higher than the 0.1289 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4975, while its 200-day Moving Average is $0.8405. Now, the first resistance to watch is $1.5333. This is followed by the second major resistance level at $1.5967. The third major resistance level sits at $1.7133. If the price goes on to break the first support level at $1.3533, it is likely to go to the next support level at $1.2367. Now, if the price goes above the second support level, the third support stands at $1.1733.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
There are 71,212K outstanding shares of the company, which has a market capitalization of 104.68 million. As of now, sales total 570 K while income totals -26,430 K. Its latest quarter income was 130 K while its last quarter net income were -12,160 K.
